Potential for biosimilars in rheumatology in Africa
- 19 July 2023
- journal article
- editorial
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 82 (12) , 1508-1510
Abstract
Biosimilars are products which are highly similar to a reference biologic product (RBP). In Africa, regulatory frameworks for biosimilar approval are still in development in many countries and few biosimilars for rheumatic diseases are currently available. The use of biosimilar medicines in Africa provides an important opportunity to treat more rheumatology patients with biologic drugs. This editorial aims to shed a light on the potential benefits, challenges and current efforts, regarding the use of biosimilars in Africa in Rheumatology.Keywords
This publication has 12 references indexed in Scilit:
- Regulatory considerations in biosimilars: Middle East and Africa regionsPreparative Biochemistry & Biotechnology, 2021
- Pharmacoeconomics in Africa: needs, prospect and challengesJournal of Pharmaceutical Policy and Practice, 2021
- Determinants of Use of Biotherapeutics in sub-Saharan AfricaTrends in Pharmacological Sciences, 2021
- Strategies to achieve fairer prices for generic and biosimilar medicinesBMJ, 2020
- Regulatory Perspectives on Biopharmaceuticals for Chronic Inflammatory Diseases in North Africa: A Narrative ReviewThe Open Rheumatology Journal, 2019
- Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory GuidelinesFrontiers in Pharmacology, 2018
- Achieving universal health coverage in South Africa through a district health system approach: conflicting ideologies of health care provisionBMC Health Services Research, 2016
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysisThe Lancet, 2015
- A realistic approach to the evaluation of the quality management movement in health care systems: a comparison between European and African contexts based on Mintzberg's organizational modelsThe International Journal of Health Planning and Management, 2004
- Rheumatic diseases in African blacksSeminars in Arthritis and Rheumatism, 1994